IRON Disc Medicine Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: IRON

Price (delayed)

$29.79

Market cap

$735.25M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.42

Enterprise value

$376.97M

Highlights
IRON's EPS has soared by 92% YoY and by 65% from the previous quarter
IRON's equity has soared by 95% year-on-year but it is down by 3.9% since the previous quarter
Disc Medicine's quick ratio has soared by 95% YoY but it has decreased by 35% from the previous quarter
Disc Medicine's net income has shrunk by 63% YoY and by 19% QoQ
The company's debt has surged by 57% YoY and by 7% QoQ
Sector: Healthcare
Industry: Biotechnology
Peers: OMER OMGA

Key stats

What are the main financial stats of IRON
Market
Shares outstanding
24.68M
Market cap
$735.25M
Enterprise value
$376.97M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.08
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$76.33M
EBITDA
-$75.94M
Free cash flow
-$73.55M
Per share
EPS
-$3.42
Free cash flow per share
-$3.3
Book value per share
$14.3
Revenue per share
$0
TBVPS
$16.49
Balance sheet
Total assets
$368M
Total liabilities
$22.88M
Debt
$2.1M
Equity
$345.12M
Working capital
$344.22M
Liquidity
Debt to equity
0.01
Current ratio
17.06
Quick ratio
16.81
Net debt/EBITDA
4.72
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-22.3%
Return on equity
-23.4%
Return on invested capital
N/A
Return on capital employed
-22%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IRON stock price

How has the Disc Medicine stock price performed over time
Intraday
2.72%
1 week
8.13%
1 month
-2.33%
1 year
-5.58%
YTD
-48.42%
QTD
-52.15%

Financial performance

How have Disc Medicine's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$91.13M
Net income
-$76.43M
Gross margin
N/A
Net margin
N/A
The operating income has dropped by 92% year-on-year and by 19% since the previous quarter
Disc Medicine's net income has shrunk by 63% YoY and by 19% QoQ

Growth

What is Disc Medicine's growth rate over time

Valuation

What is Disc Medicine stock price valuation
P/E
N/A
P/B
2.08
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
IRON's EPS has soared by 92% YoY and by 65% from the previous quarter
IRON's equity has soared by 95% year-on-year but it is down by 3.9% since the previous quarter
IRON's price to book (P/B) is 28% lower than its last 4 quarters average of 2.8

Efficiency

How efficient is Disc Medicine business performance
The ROE rose by 38% YoY but it fell by 4% QoQ
Disc Medicine's return on assets has increased by 35% YoY but it has decreased by 4.7% QoQ

Dividends

What is IRON's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IRON.

Financial health

How did Disc Medicine financials performed over time
Disc Medicine's quick ratio has soared by 95% YoY but it has decreased by 35% from the previous quarter
The current ratio has soared by 94% YoY but it has contracted by 34% from the previous quarter
The company's debt is 99% lower than its equity
IRON's equity has soared by 95% year-on-year but it is down by 3.9% since the previous quarter
The company's debt has surged by 57% YoY and by 7% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.